The physiological and pharmacological role of basic fibroblast growth factor in the dopaminergic nigrostriatal system.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Brain Research Reviews

• Publication date

  2007-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.BRAINRESREV.2006.12.001PMID 17229467
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fibroblast growth factors.

  2018cited by this paper
• Unilateral intraputamenal glial cell line-derived neurotrophic factor in patients with Parkinson disease: response to 1 year of treatment and 1 year of withdrawal.

  2007cited by this paper
• Fibroblast Growth Factor (FGF)-2 and FGF Receptor 3 Are Required for the Development of the Substantia Nigra, and FGF-2 Plays a Crucial Role for the Rescue of Dopaminergic Neurons after 6-Hydroxydopamine Lesion

  2007cited by this paper
• Physiological function and putative therapeutic impact of the FGF-2 system in peripheral nerve regeneration--lessons from in vivo studies in mice and rats.

  2006cited by this paper
• Unilateral intraputaminal glial cell line-derived neurotrophic factor in patients with Parkinson disease: response to 1 year each of treatment and withdrawal.

  2006cited by this paper
• Neural Repair Strategies for Parkinson's Disease: Insights from Primate Models

  2006cited by this paper
• Enhanced De Novo Neurogenesis and Dopaminergic Neurogenesis in the Substantia Nigra of 1‐Methyl‐4‐phyenyl‐1,2,3,6‐Tetrahydropyridine‐Induced Parkinson's Disease‐Like Mice

  2006cited by this paper
• Reply: GDNF poses troubling questions for doctors, drug maker.

  2006cited by this paper
• FGF‐4 regulates neural progenitor cell proliferation and neuronal differentiation

  2006cited by this paper
• Fibroblast growth factor receptor signaling affects development and function of dopamine neurons – inhibition results in a schizophrenia‐like syndrome in transgenic mice

  2006cited by this paper
• GDNF poses troubling questions for doctors, drug maker. Toxicity, negative outcome raise doubts.

  2006cited by this paper
• FGF‐2 deficiency does not alter vulnerability of the dopaminergic nigrostriatal system towards MPTP intoxication in mice

  2006cited by this paper
• Dopaminergic properties and function after grafting of attached neural precursor cultures.

  2006cited by this paper
• Receptor Specificity of the Fibroblast Growth Factor Family

  2006cited by this paper
• Apomorphine‐induced activation of dopamine receptors modulates FGF‐2 expression in astrocytic cultures and promotes survival of dopaminergic neurons

  2006cited by this paper
• Nucleofection Is the Most Efficient Nonviral Transfection Method for Neuronal Stem Cells Derived from Ventral Mesencephali with No Changes in Cell Composition or Dopaminergic Fate

  2006cited by this paper
• Basic Fibroblast Growth Factor Protects against Rotenone-Induced Dopaminergic Cell Death through Activation of Extracellular Signal-Regulated Kinases 1/2 and Phosphatidylinositol-3 Kinase Pathways

  2006cited by this paper
• Gene expression patterns for GDNF and its receptors in the human putamen affected by Parkinson's disease: a real-time PCR study.

  2006cited by this paper
• Brain-Derived Neurotrophic Factor Is Required for the Establishment of the Proper Number of Dopaminergic Neurons in the Substantia Nigra Pars Compacta

  2005cited by this paper
• Transfection of tyrosine kinase deleted FGF receptor-1 into rat brain substantia nigra reduces the number of tyrosine hydroxylase expressing neurons and decreases concentration levels of striatal dopamine.

  2005cited by this paper
• FGF-21 as a novel metabolic regulator.

  2005cited by this paper
• Cell therapy for Parkinson's disease: problems and prospects.

  2005cited by this paper
• Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23.

  2005cited by this paper
• Cell responses to FGFR3 signalling: growth, differentiation and apoptosis.

  2005cited by this paper
• Regulation of neuronal death and calcitonin gene-related peptide by fibroblast growth factor-2 and FGFR3 after peripheral nerve injury: evidence from mouse mutants.

  2005cited by this paper
• Fibroblast growth factor homologous factors: evolution, structure, and function.

  2005cited by this paper
• Mechanisms underlying differential responses to FGF signaling.

  2005cited by this paper
• Glial cell line-derived neurotrophic factor (GDNF) gene expression in the human brain: A post mortem in situ hybridization study with special reference to Parkinson's disease

  2005cited by this paper
• FGF22 and its close relatives are presynaptic organizing molecules in the mammalian brain.

  2004cited by this paper
• Fibroblast growth factor receptor 3 signaling regulates injury-related effects in the peripheral nervous system.

  2004cited by this paper
• Fibroblast growth factor-20 promotes the differentiation of Nurr1-overexpressing neural stem cells into tyrosine hydroxylase-positive neurons.

  2004cited by this paper
• Localized striatal delivery of GDNF as a treatment for Parkinson disease

  2004cited by this paper
• Mouse FGF15 is the ortholog of human and chick FGF19, but is not uniquely required for otic induction.

  2004cited by this paper
• Expression of the fibroblast growth factor-2 isoforms and the FGF receptor 1-4 transcripts in the rat model system of Parkinson's disease.

  2004cited by this paper
• FGF 22 and Its Close Relatives Are Presynaptic Organizing Molecules in the Mammalian Brain apses

  2004cited by this paper
• Localization of basic fibroblast growth factor in a subpopulation of rat sensory neurons

  2004cited by this paper
• Evolution of the Fgf and Fgfr gene families.

  2004cited by this paper
• Enhanced survival, reinnervation, and functional recovery of intrastriatal dopamine grafts co-transplanted with Schwann cells overexpressing high molecular weight FGF-2 isoforms.

  2004cited by this paper
• Factors promoting survival of mesencephalic dopaminergic neurons

  2004cited by this paper
• Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice.

  2004cited by this paper
• Fibroblast growth factors as regulators of central nervous system development and function.

  2003cited by this paper
• Fibroblast Growth Factor Receptor 3 Signaling Regulates the Onset of Oligodendrocyte Terminal Differentiation

  2003cited by this paper
• Fibroblast growth factors and their receptors in the central nervous system

  2003cited by this paper
• Differential Intranuclear Localization of Fibroblast Growth Factor-2 Isoforms and Specific Interaction with the Survival of Motoneuron Protein*

  2003cited by this paper
• Preferential neurotrophic activity of fibroblast growth factor‐20 for dopaminergic neurons through fibroblast growth factor receptor‐1c

  2003cited by this paper
• Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18.

  2002cited by this paper
• Animal models of Parkinson's disease.

  2002cited by this paper
• Functions of FGF signalling from the apical ectodermal ridge in limb development

  2002cited by this paper
• Fibroblast Growth Factors In The Developing Central Nervous System

  2001cited by this paper
• The role of basic fibroblast growth factor in peripheral nerve regeneration

  2001cited by this paper
• Depletion of glial cell line-derived neurotrophic factor in substantia nigra neurons of Parkinson's disease brain.

  2001cited by this paper
• Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease.

  2001cited by this paper
• Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor Are Required Simultaneously for Survival of Dopaminergic Primary Sensory Neurons In Vivo

  2001cited by this paper
• Fibroblast growth factors

  2001cited by this paper
• Molecular cloning and developmental expression of rat fibroblast growth factor receptor 3

  2001cited by this paper
• Identification of a novel fibroblast growth factor, FGF-22, preferentially expressed in the inner root sheath of the hair follicle.

  2001cited by this paper
• Basic Fibroblast Growth Factor (Fgf2) Is Necessary for Cell Proliferation and Neurogenesis in the Developing Cerebral Cortex

  2000cited by this paper
• Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain.

  2000cited by this paper
• Long-Term rAAV-Mediated Gene Transfer of GDNF in the Rat Parkinson's Model: Intrastriatal But Not Intranigral Transduction Promotes Functional Regeneration in the Lesioned Nigrostriatal System

  2000cited by this paper
• Glial Cell Line-Derived Neurotrophic Factor Is Essential for Postnatal Survival of Midbrain Dopamine Neurons

  2000cited by this paper
• Expression of FGFR1, FGFR2 and FGFR3 during early neural development in the chick embryo.

  2000cited by this paper
• Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.

  2000cited by this paper
• Survival and differentiation of dopaminergic mesencephalic neurons are promoted by dopamine-mediated induction of FGF-2 in striatal astroglial cells.

  2000cited by this paper
• Improving the Survival of Grafted Dopaminergic Neurons: A Review over Current Approaches

  2000cited by this paper
• Fgf8 signalling from the AER is essential for normal limb development

  2000cited by this paper
• Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF.

  2000cited by this paper
• Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra.

  2000cited by this paper
• Fibroblast Growth Factor-16 Is a Growth Factor for Embryonic Brown Adipocytes*

  2000cited by this paper
• The high molecular weight fibroblast growth factor-2 isoforms (21,000 mol. wt and 23,000 mol. wt) mediate neurotrophic activity on rat embryonic mesencephalic dopaminergic neurons in vitro.

  2000cited by this paper
• Compensation by Fibroblast Growth Factor 1 (FGF1) Does Not Account for the Mild Phenotypic Defects Observed in FGF2 Null Mice

  2000cited by this paper
• FGF-20, a novel neurotrophic factor, preferentially expressed in the substantia nigra pars compacta of rat brain.

  2000cited by this paper
• Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease.

  2000cited by this paper
• Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra.

  1999cited by this paper
• Prospects for new restorative and neuroprotective treatments in Parkinson's disease

  1999cited by this paper
• From entropy to Duino

  1999cited by this paper
• Structure and expression of a novel human FGF, FGF-19, expressed in the fetal brain.

  1999cited by this paper
• FGF-19, a novel fibroblast growth factor with unique specificity for FGFR4.

  1999cited by this paper
• Targeted disruption of Fgf8 causes failure of cell migration in the gastrulating mouse embryo.

  1999cited by this paper
• Expression of trkB and trkC mRNAs by adult midbrain dopamine neurons: A double‐label in situ hybridization study

  1999cited by this paper
• Identification and characterization of a novel member of the fibroblast growth factor family

  1998cited by this paper
• Reply to “Survival of expanded dopaminergic precursors is critical for clinical trials”

  1998cited by this paper
• Parkinson's disease. Second of two parts.

  1998cited by this paper
• Immunohistochemical analyses of fibroblast growth factor receptor-1 in the human substantia nigra. Comparison between normal and Parkinson's disease cases.

  1998cited by this paper
• Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat.

  1998cited by this paper
• Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor.

  1998cited by this paper
• Structure and expression of a novel member, FGF-16, on the fibroblast growth factor family.

  1998cited by this paper
• Medial nigral dopamine neurons have rich neurotrophin support in humans

  1998cited by this paper
• Fibroblast Growth Factor Receptor 3 Mutations Promote Apoptosis but Do Not Alter Chondrocyte Proliferation in Thanatophoric Dysplasia*

  1998cited by this paper
• A null mutation in TGF-α leads to a reduction in midbrain dopaminergic neurons in the substantia nigra

  1998cited by this paper
• Impaired cerebral cortex development and blood pressure regulation in FGF‐2‐deficient mice

  1998cited by this paper
• Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats

  1998cited by this paper
• Neuronal localization of fibroblast growth factor-9 immunoreactivity in human and rat brain.

  1998cited by this paper
• Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats.

  1997cited by this paper
• Morphological Alterations in the Peripheral and Central Nervous Systems of Mice Lacking Glial Cell Line-Derived Neurotrophic Factor (GDNF): Immunohistochemical Studies

  1997cited by this paper
• Comparative localization of fibroblast growth factor receptor‐1, ‐2, and ‐3 mRNAs in the rat brain: In situ hybridization analysis

  1997cited by this paper
• Localization, Differential Expression and Retrograde Axonal Transport Suggest Physiological Role of FGF‐2 in Spinal Autonomic Neurons of the Rat

  1997cited by this paper
• Murine FGF-12 and FGF-13: expression in embryonic nervous system, connective tissue and heart.

  1997cited by this paper
• Receptor Specificity of the Fibroblast Growth Factor Family*

  1996cited by this paper
• Expression of the fibroblast growth factor family and their receptor family genes during mouse brain development.

  1996cited by this paper
• Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by instrastriatal 6-hydroxydopamine in the rat.

  1996cited by this paper

• FGF-FGFR Signaling in Parkinson's Disease: Mechanistic Links to Ferroptosis and Neuroprotection.

  2026cites this paper
• Functional characteristics, intercellular interactions and pathophysiological associations of astrocytes in Parkinson’s disease

  2025cites this paper
• Research progress on intranasal treatment for Parkinson's disease

  2024cites this paper
• A dual‐omics approach on the effects of fibroblast growth factor‐2 (FGF‐2) on ventral tegmental area dopaminergic neurons in response to alcohol consumption in mice

  2024cites this paper
• Chronic Voluntary Alcohol Consumption Alters Promoter Methylation and Expression of Fgf-2 and Fgfr1

  2023cites this paper
• FGF2 activity regulates operant alcohol self-administration and mesolimbic dopamine transmission.

  2023cites this paper
• Astrocytes in Parkinson’s Disease: From Role to Possible Intervention

  2023cites this paper
• FGF2 is an endogenous regulator of alcohol reward and consumption

  2021cites this paper
• Trophic Factors as Potential Therapies for Treatment of Major Mental Disorders.

  2021cites this paper
• FGF, Mechanism of Action, Role in Parkinson’s Disease, and Therapeutics

  2021cites this paper
• Fibroblast Growth Factor Signalling in the Diseased Nervous System

  2021cites this paper
• Engrafted primary type-2 astrocytes improve the recovery of the nigrostriatal pathway in a rat model of Parkinson's disease

  2020cites this paper
• Challenges of BDNF-based therapies: from common to rare diseases.

  2020cites this paper
• What Can We Learn from FGF-2 Isoform-Specific Mouse Mutants? Differential Insights into FGF-2 Physiology In Vivo

  2020cites this paper
• MANF AS A NEW REGULATOR OF THE UNFOLDED PROTEIN RESPONSE AND MAINTENANCE OF PANCREATIC β-CELLS IN MICE

  2020cites this paper
• In Vivo and In Vitro Evaluation of a Novel Hyaluronic Acid–Laminin Hydrogel as Luminal Filler and Carrier System for Genetically Engineered Schwann Cells in Critical Gap Length Tubular Peripheral Nerve Graft in Rats

  2020cites this paper
• Fibroblast growth factor: Promising target for schizophrenia.

  2020cites this paper
• Low serum levels of fibroblast growth factor 2 in Gunn rats: a hyperbilirubinemia animal model of schizophrenic symptoms.

  2020cites this paper
• Inhibition of FGF Receptor-1 Suppresses Alcohol Consumption: Role of PI3 Kinase Signaling in Dorsomedial Striatum

  2019cites this paper
• The development of a rabies virus glycoprotein derivative for targeted nanoparticulate drug delivery across an in vitro blood brain barrier model

  2019cites this paper
• Primary Cilia–An Underexplored Topic in Major Mental Illness

  2019cites this paper
• FGF-2 isoforms influence the development of dopaminergic neurons in the murine substantia nigra, but not anxiety-like behavior, stress susceptibility, or locomotor behavior.

  2019cites this paper
• The role of fibroblast growth factor 2 in drug addiction

  2018cites this paper
• Methylation changes and aberrant expression of FGFR3 in Lewy body disease neurons.

  2018cites this paper
• Fibroblast Growth Factor 2 in the Dorsomedial Striatum Is a Novel Positive Regulator of Alcohol Consumption

  2017cites this paper
• Significance of Basic Fibroblast Growth Factor ( BFGF ) in The Development of Postresuscitation Changes in Population of Cerebellar Purkinje Cells

  2016cites this paper
• An electrophysiological study on the effects of BDNF and FGF2 on voltage dependent Ca(2+) currents in developing human striatal primordium.

  2016cites this paper
• ЗНАЧЕНИЕ ОСНОВНОГО ФАКТОРА РОСТА ФИБРОБЛАСТОВ (BFGF) В РАЗВИТИИ ПОСТРЕАНИМАЦИОННЫХ ИЗМЕНЕНИЙ ПОПУЛЯЦИИ КЛЕТОК ПУРКИНЬЕ МОЗЖЕЧКА

  2016cites this paper
• High production in E. coli of biologically active recombinant human fibroblast growth factor 20 and its neuroprotective effects

  2016cites this paper
• Prolonged and Intermittent Bilateral Common Carotid Artery Occlusion Induces Brain Lipidome Changes in a Rat Stroke Model

  2016cites this paper
• Human Basic Fibroblast Growth Factor Inhibits Tau Phosphorylation via the PI3K/Akt-GSK3β Signaling Pathway in a 6-Hydroxydopamine-Induced Model of Parkinson's Disease

  2016cites this paper
• Current disease modifying approaches to treat Parkinson’s disease

  2016cites this paper
• Neuroprotective Role of Basic Fibroblast Growth Factor in Ischemic Brain Lesion : a Review

  2016cites this paper
• Increased innervation of forebrain targets by midbrain dopaminergic neurons in the absence of FGF-2.

  2016cites this paper
• Fibroblast growth factor 23 signaling in hippocampal cells: impact on neuronal morphology and synaptic density

  2016cites this paper
• Transplantation of fetal ventral mesencephalic progenitor cells overexpressing high molecular weight fibroblast growth factor 2 isoforms in 6-hydroxydopamine lesioned rats.

  2015cites this paper
• Mesenchymal Stem Cells Support Neuronal Fiber Growth in an Organotypic Brain Slice Co-Culture Model

  2015cites this paper
• Multifaceted roles of BDNF and FGF2 in human striatal primordium development. An in vitro study.

  2014cites this paper
• Functional differentiation of midbrain neurons from human cord blood-derived induced pluripotent stem cells

  2014cites this paper
• Activated astrocytes enhance the dopaminergic differentiation of stem cells and promote brain repair through bFGF

  2014cites this paper
• Alternative therapies for Morbus Parkinson: Effects of tactile stimulation in a rodent model of Parkinsons disease and induced pluripotent stem cells as a new source for neurotransplantation - therapy

  2014cites this paper
• The Proform of Glia Cell Line-Derived Neurotrophic Factor: a Potentially Biologically Active Protein

  2014cites this paper
• Fibroblast Growth Factors in Neurodevelopment and Psychopathology

  2013cites this paper
• dult hemiparkinsonian rats do not benefit from tactile stimulation

  2013cites this paper
• Schizophrenia: A neurodevelopmental disorder — Integrative genomic hypothesis and therapeutic implications from a transgenic mouse model

  2013cites this paper
• Growth factor signaling and memory formation: temporal and spatial integration of a molecular network

  2013cites this paper
• Neuronal nicotinic receptor agonists ameliorate spontaneous motor asymmetries and motor discoordination in a unilateral mouse model of Parkinson's disease.

  2013cites this paper
• Avaliação do potencial efeito antipsicótico da miricitrina em modelos animais

  2013cites this paper
• Silymarin- and melatonin-mediated changes in the expression of selected genes in pesticides-induced Parkinsonism

  2013cites this paper
• From risk genes to psychiatric phenotypes - Studies of fibroblast growth factor-related and genome-wide genetic variants in humans and mice

  2013cites this paper
• Fibroblast growth factor 2 regulates dopaminergic neuron development in vivo

  2012cites this paper
• The Colayer Method as an Efficient Way to Genetically Modify Mesencephalic Progenitor Cells Transplanted into 6-OHDA Rat Model of Parkinson's Disease

  2012cites this paper
• Ephrin-A1-Mediated Dopaminergic Neurogenesis and Angiogenesis in a Rat Model of Parkinson's Disease

  2012cites this paper
• Glia: an emerging target for neurological disease therapy

  2012cites this paper
• Extracellular cysteine (Cys)/cystine (CySS) redox regulates metabotropic glutamate receptor 5 activity.

  2012cites this paper
• Basic Fibroblast Growth Factor Protects C17.2 Cells from Radiation‐Induced Injury through ERK1/2

  2012cites this paper
• Neonatal fibroblast growth factor treatment enhances cocaine sensitization.

  2012cites this paper
• Neuroprotective and memory enhancing properties of a dual agonist of the FGF receptor and NCAM.

  2012cites this paper
• Selective kinase inhibitors as tools for neuroscience research.

  2012cites this paper
• Fibroblast growth factor 2 regulates adequate nigrostriatal pathway formation in mice

  2012cites this paper
• A novel strategy for intrastriatal dopaminergic cell transplantation: sequential "nest" grafting influences survival and behavioral recovery in a rat model of Parkinson's disease.

  2012cites this paper
• Unilateral 6-OHDA th-fgfr1(tk-) mouse model supports the role of FGFs in Parkinson's disease and the effects of nicotine and L-DOPA on spontaneous motor impairments

  2012cites this paper
• Regulación de la plasticidad astrocitaria por ibuprofeno y FGF2

  2011cites this paper
• FGF-2 Deficiency Does Not Influence FGF Ligand and Receptor Expression during Development of the Nigrostriatal System

  2011cites this paper
• ES cell-derived renewable and functional midbrain dopaminergic progenitors

  2011cites this paper
• Regulación de la plasticidad astrocitaria por ibuprofeno y FGF2

  2011cites this paper
• Strain Difference in the Up-Regulation of FGF-2 Protein Following a Neurotoxic Lesion of the Nigrostriatal Pathway

  2010cites this paper
• ffects of FGF receptor peptide agonists on animal behavior under normal and athological conditions

  2010cites this paper
• Novel CDNF/MANF family of neurotrophic factors

  2010cites this paper
• Fibroblast growth factors in schizophrenia.

  2010influential citation
• The Yin and Yang of VEGF and PEDF: Multifaceted Neurotrophic Factors and Their Potential in the Treatment of Parkinson’s Disease

  2010cites this paper
• Use of growth factors for the treatment of Parkinson’s disease

  2010cites this paper
• Astrocytes and therapeutics for Parkinson’s disease

  2010cites this paper
• Vascular endothelial growth factor B (VEGF-B) is up-regulated and exogenous VEGF-B is neuroprotective in a culture model of Parkinson's disease

  2009cites this paper
• Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: implications for schizophrenia, autism and cancer

  2009cites this paper
• Fibroblast growth factor 2 (FGF-2) is a novel substrate for arginine methylation by PRMT5

  2009cites this paper
• NCAM and polysialyltransferase profiles match dopaminergic marker gene expression but polysialic acid is dispensable for development of the midbrain dopamine system

  2009cites this paper
• Guanosine improves motor behavior, reduces apoptosis, and stimulates neurogenesis in rats with parkinsonism

  2009cites this paper
• Taurine stimulates proliferation of mice embryonic cultured neural progenitor cells

  2009cites this paper
• NOVEL CDNF/MANF PROTEIN FAMILY: MOLECULAR STRUCTURE, EXPRESSION AND NEUROTROPHIC ACTIVITY

  2009cites this paper
• Effect of basic fibroblast growth factor (FGF2) gene polymorphisms on SSRIs treatment response and side effects.

  2009cites this paper
• Pigment epithelium derived factor (PEDF) is neuroprotective in two in vitro models of Parkinson's disease.

  2009cites this paper
• Schwann Cells Overexpressing FGF-2 Alone or Combined with Manual Stimulation Do Not Promote Functional Recovery after Facial Nerve Injury

  2009cites this paper
• Specificity of the second messenger pathways involved in basic fibroblast growth factor‐induced survival and neurite growth in chick ciliary ganglion neurons

  2009cites this paper
• Serotonergic hyperinnervation and effective serotonin blockade in an FGF receptor developmental model of psychosis.

  2009cites this paper
• Stress and cocaine interact to modulate basic fibroblast growth factor (FGF-2) expression in rat brain

  2008cites this paper
• FGF acts as a co-transmitter through adenosine A2A receptor to regulate synaptic plasticity

  2008cites this paper
• Chronic antidepressant treatments increase basic fibroblast growth factor and fibroblast growth factor-binding protein in neurons.

  2008cites this paper
• Adrenalectomy counteracts the local modulation of astroglial fibroblast growth factor system without interfering with the pattern of 6-OHDA-induced dopamine degeneration in regions of the ventral midbrain.

  2008cites this paper
• Restorative neuroscience: concepts and perspectives.

  2008cites this paper
• Initiation to end point: the multiple roles of fibroblast growth factors in neural development

  2007cites this paper